Zevra anticipates filing MIPLYFFA sNDA in Q1 2027 as CHMP opinion remains expected in Q4

The Quick Take
Read the full report from the original publisher.
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents.
Related
Markets
China’s services PMI misses expectations at 50.8 in October, composite PMI drops to 52.0
Markets
Pfizer raises 2026 outlook to $62B-$64B revenue and $2.95-$3.05 adjusted EPS, targeting high single-digit revenue CAGR from 2028-2033
Markets
Estee Lauder targets mid-single-digit annual sales growth through 2030
Markets
